Jie Lin

Jie Lin


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
LLLan Liang
Lan Liang
CHChenming He
Chenming He
XHXue Han
Xue Han
JLJia Liu
Jia Liu
LYLiuhong Yang
Liuhong Yang
JLJie Lin
Jie Lin
Background: Precancerous lesions of gastric cancer (PLGC) represent critical stages in gastric cancer progression, with a high risk of malignancy. Current treatments, such as Helicobacter pylori eradication, show limited efficacy in reversing precancerous molecular changes. Zuojin Pill (ZJP), a traditional Chinese medicine, has demonstrated potential for treating digestive disorders and may offer a promising approach for PLGC intervention. Objective: This study aims to investigate the therapeutic effects and mechanisms of ZJP in treating PLGC, focusing on its active components, target pathways, and molecular interactions. By using advanced analytical techniques, we provide a scientific foundation for ZJP’s potential application in early gastric cancer intervention. Methods: Using ultra-high performance liquid chromatography-quadrupole orbitrap high-resolution mass spectrometry (UPLC-Q-Orbitrap HRMS), we identified active components in ZJP. A network pharmacology approach was then applied to construct a “ZJP-compound-target-disease” network. Molecular docking and molecular dynamics simulations were conducted to analyze the stability and interactions of the main active components of ZJP with core protein targets in PLGC. Animal experiments were used to validate significant targets and pathways in vivo. Results: Tangeritin, Isorhamnetin, Caffeic Acid, Azelaic Acid, and Adenosine were identified as the main active components of ZJP in the treatment of PLGC, with key targets including PIK3R1, MAPK3, SRC, JAK2, STAT3, and PIK3CA. Molecular docking and molecular dynamics simulations further confirmed the relationship between compounds and target proteins. The potential molecular mechanism of ZJP predicted by network pharmacology analysis was confirmed in PLGC rats. ZJP downregulated IL-6, TNF-α, c-myc, p-MEK1 and p-ERK1/2, effectively reversing the progression of PLGC. Conclusion: ZJP can reverse MNNG-induced PLGC, potentially through inhibition of the MEK/ERK/c-myc pathway and regulation of cellular proliferation and apoptosis.

17 December 2018 in Natural Product Research
Verified
Journal Article
Closed access
JLJie Lin
Jie Lin
GWGuoquan Wang
Guoquan Wang
LBLu Bai
Lu Bai
LYLinzhong Yu
Linzhong Yu
Abstract Two new steroidal saponins (1 and 2), along with four known ones (3 ∼ 6) were obtained from the roots and rhizomes of Maianthemum henryi, their structures were determined to be spirost-5, 25(27)-diene-lβ, 3β-diol 1-O-α-L-rhamnopyranosyl-(1 → 2)-4-O-acetyl-β-D-fucopyranoside (1), (23S, 24S)-spirost-5, 25(27)-diene-lβ, 3β, 23, 24-tetrol 1-O-α-L-rhamnopyranosyl-(1 → 2)-4-O-acetyl-β-D-fucopyranoside (2), spirost-5, 25(27)-diene-lβ, 3β-diol 1-O-α-L-rhamnopyranosyl-(1 → 2)-β-D-fucopyranoside (3), spirost-5, 25(27)-diene-lβ, 3β-diol 1-O-α-L-rhamnopyranosyl-(1 → 2)-β-D-xylopyranoside (4), Henryioside A (5)、Henryioside B (6), by physicochemical properties and spectroscopic methods. In addition, their cytotoxic activity against human HepG2 tumor cells was evaluated by MTT method and all of the compounds exhibited cytotoxicity with the cells.

13 December 2018 in Phytochemistry Letters
Verified
Journal Article
Closed access
PDF file
FQFan Qiao
Fan Qiao
JYJie Yang
Jie Yang
JLJie Lin
Jie Lin
SYSheng Yao
Sheng Yao